You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Hepachain  F.C.T - Viomix Pharmaceutical Industries S.A.E

The First Oral Tablet BCAA specified for Chronic Liver Patients
(Most Recent Liver Support)

  • Composition
  • Indication
  • Pharmacological Actions
  • Dosage
  • Warnings
  • Leaflet
  • Supporting Studies Files

Each Film Coated Tablet Contains:

L-Leucin                   450 mg
L-Isoleucin 50 mg
L-Valine 100 mg
  • Chronic liver patients
  • Chronic kidney patietns
  • Chronic fatigue syndrome

 

Please Note That:

This product is not intended to diagnose, treat, cure or prevent any disease and is not considered as a replacement for a balanced nutritional diet or for a healthy lifestyle

  • Significant Enhancement of Fatigue
  • Proven Efficacy in Activating of Albumin Synthesis
  • Significant Improvement of Nutritional Status, Prognosis & QOL in Liver Cirrhosis Patients
  • Proven Efficacy in Inhibition of Hepatocellular Carcinoma (HCC)
  • Excellent Patient Compliance
  • Excellent Safety Profile

 

To be Used Orally
2-3 tablets daily to be taken with the evening meal
Or as prescribed by the physician

► Do not exceed the daily recommended dose.
► If pregnant, nursing, taking prescription drugs or experiencing health problems, consult your healthcare professional prior to use.

Kindly, read the label Carefully, Necessary Information Still Available

Leaflet

Click to download

Supporting Studies

Rate this product


Evaluators


6

Aggregate Rating


4.83/5